INC Research, LLC

Wilmington, North Carolina 28405

0 studies enrolling now · 2 studies all time

What they study most

All Indications for Glivec/Gleevec and Tasigna, Birth Defects, Hepatitis C, Pregnancy Complications

Studies at this site

• The Ribavirin Pregnancy Registry — Stopped early
• A Global Imatinib and Nilotinib Pregnancy Exposure Registry — Completed